Once that outcome is achieved, we can submit the information (to the regulator) in the same month and eventually seek approval if the data is good," Patel said in an email interview. Unlike the Covishield, Covaxin and Sputnik V vaccines, which require two doses, Zydus Cadila’s vaccine requires three doses, with the subsequent shots administered one month after the previous dose. This meant that the vaccine required an extra month before the counting of covid-19 cases across the placebo and vaccine arms was started. After it secures authorization, Zydus plans to manufacture the vaccine at the rate of 10 million doses per month to start with and subsequently scale it up to 20 million doses. Somani, Zydus Cadila’s vaccine is likely to be the fourth in India and the second indigenously developed jab to get clearance.

Source: Mint May 04, 2021 19:18 UTC